戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 vival (time to death or the use of permanent assisted ventilation).
2  = 86 breathing unassisted, n = 97 receiving assisted ventilation).
3  in weight for gestational age or the use of assisted ventilation.
4 te insensitivity to chemical feedback during assisted ventilation.
5 4.0-78.4) times higher among cases receiving assisted ventilation.
6 older, had ARDS, and were being treated with assisted ventilation.
7 rimary safety outcome was the performance of assisted ventilation.
8 f the 42 patients with RF, 37 (88%) required assisted ventilation.
9 ity seen in critically ill patients who need assisted ventilation.
10 compressions only or chest compressions plus assisted ventilation.
11 ntensive care unit admission or the need for assisted ventilation.
12 received 30 to 60 seconds of DCC followed by assisted ventilation.
13 zard ratio for death or the use of permanent assisted ventilation, 0.53; P=0.005).
14   Twenty-six patients in each group required assisted ventilation (16.0% given diazepam and 17.6% giv
15         Peak power output decreased 20% with assisted ventilation and 41% with controlled ventilation
16          Tetanic force decreased by 14% with assisted ventilation and 48% with controlled ventilation
17  intensive care unit admission, provision of assisted ventilation and antenatal corticosteroid exposu
18 ed to increase with controlled compared with assisted ventilation and control.
19  correlation between DeltaPs measured during assisted ventilation and ICU outcomes.
20     The primary outcomes were requirement of assisted ventilation and of drugs to control muscle spas
21  We compared changes over time in the use of assisted ventilation and oxygen therapy during the newbo
22 lide antibiotic therapy and intubation, with assisted ventilation and oxygen.
23 th movement and, eventually, to the need for assisted ventilation and premature death.
24  the newborn period shortens the duration of assisted ventilation and reduces the incidence of bronch
25 ad no structural heart disease, and required assisted ventilation and whose oxygenation index was 25
26  in patients, one in healthy subjects, under assisted ventilation, and a bench study with six ventila
27 tation, were 4 days old or younger, required assisted ventilation, and had hypoxemic respiratory fail
28 more pronounced and 50% of neonates may need assisted ventilation, and occasionally naloxone.
29 y into control animals, those with 3 days of assisted ventilation, and those with controlled ventilat
30  ENO over 4 h to seven neonates who required assisted ventilation, and who had an oxygenation index o
31 sive care unit (NICU) admission, surfactant, assisted ventilation, antibiotics, and seizures.
32 ; 95% CI, 1.22-2.03), and longer duration of assisted ventilation (aOR, 1.34; 95% CI, 1.04-1.72) but
33  age, weight for gestational age, and use of assisted ventilation are presented to describe the cohor
34 a composite of surfactant therapy, immediate assisted ventilation at birth, assisted ventilation more
35 ors for survival duration included requiring assisted ventilation at the time of transplant, continuo
36                     They were then placed on assisted ventilation, awakened, and resuscitated with la
37       This study did not show that providing assisted ventilation before cord clamping in extremely p
38 und the feasibility, safety, and efficacy of assisted ventilation before cord clamping may provide ad
39                                           No assisted ventilation cardiopulmonary resuscitation resul
40  randomly assigned to chest compressions and assisted ventilation (CC+V), chest compressions only (CC
41                          Conclusions: During assisted ventilation, DeltaP and normalized compliance a
42 nspiratory effort during the first 3 days of assisted ventilation did not differ between survivors an
43 of prehospital single-rescuer bystander CPR, assisted ventilation did not improve outcome.
44 hom the rate of respiratory events requiring assisted ventilation differed from the overall rate of e
45 ional studies are needed before implementing assisted ventilation during DCC in clinical practice.
46 morrhage, this secondary analysis found that assisted ventilation during DCC was associated with less
47                                              Assisted ventilation during delayed cord clamping (DCC)
48                                    Providing assisted ventilation during delayed umbilical cord clamp
49                    We evaluated the need for assisted ventilation during simulated single-rescuer bys
50                    We evaluated the need for assisted ventilation during simulated single-rescuer bys
51 infants randomized to receive 120 seconds of assisted ventilation followed by cord clamping vs delaye
52    Regional rates of both NICU admission and assisted ventilation following delivery were positively
53                                              Assisted ventilation for extremely preterm infants (<28
54  ventilation may be as effective as CPR with assisted ventilation for ventricular fibrillatory cardia
55 titoxin and supportive care that may include assisted ventilation for weeks or months.
56 ve pressure ventilation compared with the no assisted ventilation group (117 +/- 29 and 41 +/- 21 vs.
57                  Patients who were receiving assisted ventilation, had an invasive airway in place, o
58          The optimal timing for switching to assisted ventilation has not been studied.
59 tilation (PAV) is a newer mode that delivers assisted ventilation in proportion to patient effort.
60 al ventilation, switching from controlled to assisted ventilation is a crucial milestone toward venti
61 clusions: Early switching from controlled to assisted ventilation is associated with shorter duration
62 controlled ventilation, but its value during assisted ventilation is unknown.
63  cardiopulmonary resuscitation (CPR) without assisted ventilation may be as effective as CPR with ass
64 ditis were more likely to be listed while on assisted ventilation, mechanical circulatory support and
65 py, immediate assisted ventilation at birth, assisted ventilation more than 6 hours in duration, and/
66 s chest compressions (100/min) and either no assisted ventilation (n = 9) or 10 positive pressure ven
67 ic and pathologic comparison of two modes of assisted ventilation, nasal intermittent positive-pressu
68                    Aspects of care including assisted ventilation, nutrition, and patient autonomy ar
69 cial to the management of children requiring assisted ventilation on Paediatric Intensive Care Units
70 lation (CC+V), chest compressions only (CC), assisted ventilation only (V), or no bystander CPR (cont
71 U) level was classified as A, restriction on assisted ventilation or no surgery; B, major surgery; or
72 e stimulation to advanced airway management, assisted ventilation, oxygen therapy, intravascular acce
73 thing unassisted versus 89 (91.8%) receiving assisted ventilation (P < 0.001).
74 , 35 months): death, tracheostomy, permanent assisted ventilation (PAV) and first hospitalisation.
75 erse events including the use of flumazenil, assisted ventilation, permanent injury or death, and tem
76                After 24 hrs, four of nine no assisted ventilation pigs were alive with a mean cerebra
77 g unassisted versus 39.6% of those receiving assisted ventilation presented without an arterial pulse
78 , including data on the duration and type of assisted ventilation provided, the duration of oxygen th
79 aphragm, and left and right separately), but assisted ventilation rating and forced vital capacity sh
80 ion of continuous chest compressions without assisted ventilations resulted in significantly better 2
81                              The duration of assisted ventilation rose substantially over time, with
82  In the second category, which concerns only assisted ventilation, the respiratory rate may induce in
83 zed category, concerning both controlled and assisted ventilation, the respiratory rate per se may pr
84 e ratio [IRR], 2.34; 95% CI, 2.13-2.57), and assisted ventilation use decreased from 8.9% to 8.2% (ad
85                    No change was observed in assisted ventilation use for more than 6 hours (adjusted
86 eroid use, any assisted ventilation use, and assisted ventilation use for more than 6 hours immediate
87                             Steroid use, any assisted ventilation use, and assisted ventilation use f
88     The rate of respiratory events requiring assisted ventilation was not significantly different amo
89 ted, the majority (70.4%) of those receiving assisted ventilation who experienced hypotension or card
90 , animals were randomly assigned to 6 hrs of assisted ventilation with pressure support ventilation,
91 ons of continuous chest compressions without assisted ventilations with 30:2 CPR in a swine model of